Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel O Stram

Showing results (201-210 of 294) with videos related to

Pageof 30
Sort By:
Blood Advances|January 4, 2018
Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sexAlyssa I Clay-Gilmour, Theresa Hahn, Leah M Preus, et al.
BMC Cancer|July 31, 2009
Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)Federico Canzian, Rudolf Kaaks, David G Cox, et al.
Journal of the National Cancer Institute|May 15, 2014
Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survivalYin Cao, Sara Lindström, Fredrick Schumacher, et al.
International Journal of Cancer|July 16, 2016
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancerAlice W Lee, Ashley Bomkamp, Elisa V Bandera, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 28, 2012
Evaluating genetic risk for prostate cancer among Japanese and LatinosIona Cheng, Gary K Chen, Hidewaki Nakagawa, et al.
Breast Cancer Research : BCR|September 22, 2006
A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)David G Cox, Hélène Blanché, Celeste L Pearce, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2009
CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort ConsortiumRuth C Travis, Fredrick Schumacher, Joel N Hirschhorn, et al.
The Prostate|August 14, 2015
ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)Sarah C Markt, Irene M Shui, Robert H Unger, et al.
International Journal of Cancer|October 16, 2007
Haplotypes of the estrogen receptor beta gene and breast cancer risk, David G Cox, Philip Bretsky, et al.
Plos One|July 4, 2008
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3)Alpa V Patel, Iona Cheng, Federico Canzian, et al.
Pageof 30

Showing results (201-210 of 294) with videos related to

Sort By:
Pageof 30
Blood Advances|January 4, 2018
Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sexAlyssa I Clay-Gilmour, Theresa Hahn, Leah M Preus, et al.
BMC Cancer|July 31, 2009
Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)Federico Canzian, Rudolf Kaaks, David G Cox, et al.
Journal of the National Cancer Institute|May 15, 2014
Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survivalYin Cao, Sara Lindström, Fredrick Schumacher, et al.
International Journal of Cancer|July 16, 2016
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancerAlice W Lee, Ashley Bomkamp, Elisa V Bandera, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 28, 2012
Evaluating genetic risk for prostate cancer among Japanese and LatinosIona Cheng, Gary K Chen, Hidewaki Nakagawa, et al.
Breast Cancer Research : BCR|September 22, 2006
A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)David G Cox, Hélène Blanché, Celeste L Pearce, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2009
CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort ConsortiumRuth C Travis, Fredrick Schumacher, Joel N Hirschhorn, et al.
The Prostate|August 14, 2015
ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)Sarah C Markt, Irene M Shui, Robert H Unger, et al.
International Journal of Cancer|October 16, 2007
Haplotypes of the estrogen receptor beta gene and breast cancer risk, David G Cox, Philip Bretsky, et al.
Plos One|July 4, 2008
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3)Alpa V Patel, Iona Cheng, Federico Canzian, et al.
Pageof 30